Market By Product, Test Type, Technology And Geography | Forecast 2019-2027
After analyzing the North American newborn screening market in detail, Triton Market research has concluded that the market is estimated to grow with a CAGR of 13.93% in the forecast period of 2019-2027.
The countries that have been scrutinized in the North America newborn screening market are:
• The United States
• Canada
Report scope can be customized per your requirements. Request For Customization
The newborn screening market in Canada is mainly driven by the prevalence of hearing disorders, along with the rising critical congenital heart diseases in newborn babies in the country. The prevalent diseases in newborn babies in Canada mainly include Biotinidase deficiency, Carnitine uptake defect, congenital adrenal hyperplasia, critical congenital heart disease, and severe combined immune deficiency. According to the screening test conducted by Newborn Screening Ontario, around 300 newborn babies would screen positive for CCHD, and about 50 to100 would end up being diagnosed with it. According to the organization, around 29 diseases were tested that impact newborn babies. The Canada newborn screening market is expected to be on the rise owing to the prevalence of hearing disorders, along with the rising critical congenital heart diseases in newborn babies of the country, further augmenting the growth of the newborn screening market in Canada and the adoption of newborn screening in the semi-urban and urban regions of Canada.
The United States newborn screening market is mainly driven by the rising prevalence of congenital disorders considering newborn babies, along with the rules and regulations related to newborn screening in the country. According to the Centre for Disease Control & Prevention, every baby born in the US should be screened, which makes newborn screening a law-abiding factor in the country. According to the American Academy of Pediatrics, newborn screening is a state public health service in the United States, which reaches to over 4 million babies born in the country every year. According to Baby’s First Test Organization, in the US, most states in the country screen for around 29 out of 34 conditions which were recommended by the Discretionary Advisory Committee on inheritable disorders in children. The newborn screening market in the US is expected to be on the upsurging trend owing to the rising prevalence of congenital disorders in newborn babies, along with the rules and regulations related to newborn screening is impacting the growth of the market in the United States.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA NEWBORN SCREENING MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. KEY
INSIGHTS
2.2.1. SUPPORTIVE
GOVERNMENT POLICIES IN THE US AND CANADA
2.2.2. DEMAND
FOR NEWBORN SCREENING INSTRUMENTS IS RISING STEADILY
2.2.3. GROWTH
IN DRY BLOOD SPOT TEST
2.2.4. TECHNIQUES
USED IN NEWBORN SCREENING TESTS
2.3. EVOLUTION
& TRANSITION OF NEWBORN SCREENING
2.4. PORTER’S
FIVE FORCE ANALYSIS
2.4.1. THREAT
OF NEW ENTRANTS
2.4.2. THREAT
OF SUBSTITUTE
2.4.3. BARGAINING
POWER OF SUPPLIERS
2.4.4. BARGAINING
POWER OF BUYERS
2.4.5. THREAT
OF COMPETITIVE RIVALRY
2.5. KEY
IMPACT ANALYSIS
2.5.1. RELIABILITY
2.5.2. COST
2.5.3. AVAILABILITY
2.5.4. TECHNOLOGICAL
ADVANCEMENT
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. INDUSTRY
COMPONENTS
2.8.1. RAW
MATERIAL SUPPLIERS
2.8.2. MANUFACTURERS
2.8.3. DISTRIBUTORS
2.8.4. END-USERS
2.9. REGULATORY
FRAMEWORK
2.10. INDUSTRY
PLAYER POSITIONING
2.11. KEY
MARKET STRATEGIES
2.11.1. PRODUCT
LAUNCH
2.12. MARKET
DRIVERS
2.12.1. INCREASE
IN OCCURRENCES OF NEWBORN DISEASES
2.12.2. GROWING
NUMBER OF INFANTS WITH BIRTH DEFECT
2.12.3. BACKING
OF GOVERNMENT TOWARDS NEWBORN CHILD HEALTH
2.12.4. RISING
AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE
2.13. MARKET
RESTRAINTS
2.13.1. SOCIO-ECONOMIC
HURDLES IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING
2.14. MARKET
OPPORTUNITIES
2.14.1. NEWBORN
SCREENING HELPS IN EARLY IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS
2.14.2. TECHNOLOGICAL
ADVANCEMENTS IN NEWBORN SCREENING
2.14.3. INCREASE
IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE
2.15. MARKET
CHALLENGES
2.15.1. DEARTH
OF SKILLED PROFESSIONAL IN HEALTHCARE INDUSTRY
2.15.2. MAINTENANCE
OF EQUIPMENT IN HOSPITAL
3. NEWBORN
SCREENING MARKET OUTLOOK - BY PRODUCT
3.1. NEWBORN
SCREENING INSTRUMENTS
3.2. NEWBORN
SCREENING REAGENTS & ASSAY KITS
4. NEWBORN
SCREENING MARKET OUTLOOK - BY TEST TYPE
4.1. HEARING
SCREEN TEST
4.2. CRITICAL
CONGENITAL HEART DISEASE (CCHD) TEST
4.3. DRY
BLOOD SPOT TEST
5. NEWBORN
SCREENING MARKET OUTLOOK - BY TECHNOLOGY
5.1. TANDEM
MASS SPECTROMETRY
5.2. PULSE
OXIMETRY
5.3. ENZYME-BASED
ASSAYS
5.4. DNA-BASED
ASSAYS
5.5. ELECTROPHORESIS
5.6. OTHERS
6. NEWBORN
SCREENING MARKET - REGIONAL OUTLOOK
6.1. UNITED
STATES
6.2. CANADA
7. COMPETITIVE
LANDSCAPE
7.1. SCIEX
7.2. BIOTEK
INSTRUMENTS, INC.
7.3. BIO-RAD
LABORATORIES, INC.
7.4. CARDINAL
HEALTH, INC.
7.5. GE
HEALTHCARE, LIMITED
7.6. AGILENT
TECHNOLOGIES, INC.
7.7. MASIMO
CORPORATION
7.8. NATUS
MEDICAL, INCORPORATED
7.9. MEDTRONIC
PLC
7.10. THERMO
FISHER SCIENTIFIC, INC.
7.11. NEOGEN
LABS PVT. LTD.
7.12. PERKINELMER,
INC.
7.13. ZENTECH
S.A.
7.14. WATERS
CORPORATION
7.15. TRIVITRON
HEALTHCARE
8. METHODOLOGY
& SCOPE
8.1. RESEARCH
SCOPE
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA
NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS
INDEX
TABLE 3: VENDOR
SCORECARD
TABLE 4: REGULATORY
FRAMEWORK
TABLE 5: LIST OF
PRODUCT LAUNCHES
TABLE 6: LEADING CAUSE
OF INFANT DEATHS IN THE UNITED STATES
TABLE 7: NORTH AMERICA
NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)
TABLE 8: NORTH AMERICA
NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)
TABLE 9: NORTH AMERICA
NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)
TABLE 10: NORTH AMERICA
NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE
FORCE ANALYSIS
FIGURE 2: KEY BUYING
IMPACT ANALYSIS
FIGURE 3: INDUSTRY
COMPONENTS
FIGURE 4: INDUSTRY
PLAYER POSITIONING IN 2018 (IN %)
FIGURE 5: NORTH AMERICA
NEWBORN SCREENING MARKET, BY NEWBORN SCREENING INSTRUMENTS, 2019-2027 (IN $
MILLION)
FIGURE 6: NORTH AMERICA
NEWBORN SCREENING MARKET, BY NEWBORN SCREENING REAGENTS & ASSAY KITS,
2019-2027 (IN $ MILLION)
FIGURE 7: NORTH AMERICA
NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST, 2019-2027 (IN $ MILLION)
FIGURE 8: NORTH AMERICA
NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST,
2019-2027 (IN $ MILLION)
FIGURE 9: NORTH AMERICA
NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST, 2019-2027 (IN $ MILLION)
FIGURE 10: NORTH
AMERICA NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY, 2019-2027 (IN $
MILLION)
FIGURE 11: NORTH
AMERICA NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027 (IN $ MILLION)
FIGURE 12: NORTH
AMERICA NEWBORN SCREENING MARKET, BY ENZYME-BASED ASSAY, 2019-2027 (IN $
MILLION)
FIGURE 13: NORTH
AMERICA NEWBORN SCREENING MARKET, BY DNA-BASED ASSAYS, 2019-2027 (IN $ MILLION)
FIGURE 14: NORTH
AMERICA NEWBORN SCREENING MARKET, BY ELECTROPHORESIS, 2019-2027 (IN $ MILLION)
FIGURE 15: NORTH
AMERICA NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)
FIGURE 16: NORTH
AMERICA NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 17: UNITED
STATES NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 18: CANADA
NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)